| What is Scrip Regulatory Affairs?
Scrip Regulatory Affairs (SRA) is the leading provider of regulatory news, analysis & practical guidance for the pharma, biotech and medtech industries. SRA helps its readers – your peers and competitors in the pharma/biotech/medtech industries – avoid costly regulatory mistakes and is an indispensable guide to rules governing the development, launch and post-market surveillance of drugs and medical devices worldwide. Scrip Regulatory Affairs provides you with a truly relevant international and independent perspective, keeping readers fully informed of the latest developments.
Scripregulatoryaffairs.com delivers up-to-the-minute news and analysis on the key regulatory, legal and policy issues facing the global pharma and medtech industries. SRA also publishes a monthly publication (PDF or hardcopy), providing key regulatory news, analysis, commentary and practical advice. SRA covers: regulatory agencies and legislation, marketing application requirements and guidelines, research and development, patents and intellectual property, international harmonisation, drug/medical device safety, pharmacovigilance, pharmacoeconomics,etc. Take a free 7 day trial subscription - it's the perfect way for you to try our service.
Scrip Regulatory Affairs
Informa UK Ltd
119, Farringdon Road
London
EC1R 3DA
Tel: +44 (0) 20 7017 5000
Fax: +44 (0) 20 7017 7850
Email: regulatory@informa.com
Editorial Board
Scrip Regulatory Affairs’ editorial board comprises a range of regulatory and legal experts from industry and agencies alike.  |  |  |  | | Richard Bergström – Director General, EFPIA, Brussels, Belgium | Marja de Jong, Director, Medidas
Wijk bij Duurstede
The Netherlands | Dr Anne Dupraz Poiseau, Project director, medical devices and combination products, Voisin Consulting, Boulogne, France | Peter Bogaert – Covington & Burling LLP, Brussels, Belgium |  |  |  |  | | Manuel Campolini – Member of the Brussels Bar, Stibbe, Brussels, Belgium | Geneviève Michaux
Of counsel
Covington & Burling
Brussels, Belgium | Ian Dodds-Smith – Arnold and Porter, London, UK | Brenton James – Consultant in Strategic, Regulatory Affairs in the EU, Ascot, UK |  |  |  |  | | Maarten Meulenbelt – Sidley Austin LLP, Brussels, Belgium | Prof Tamás L Paál – National Institute of Pharmacy (formerly)
Budapest, Hungary | Carmen Langley – Ferring Pharmaceuticals Pty Ltd, Sydney | Isaac Setton – Teva Pharmaceutical Industries Ltd, Petah Tikva, Israel |  |  |  | | | John Lisman – Lisman Legal Life sciences, Nieuwerbrug, the Netherlands | Dr Karen Becker, IndigoBay Ventures LLC, Rockville MD, US | Dr Manuel Zahn – 3R Pharma Consulting, Dobel, Germany | Maurice Freeman,
M F Freeman Associates, UK |
Editorial Correspondents:
Scrip Regulatory Affairs’ correspondents are based locally around the world. To contact a correspondent please email regulatory@informa.com
Subscriptions
New Subscriptions:
Drew Edwards – drew.edwards@informa.com
+44 (0) 207 017 74400
Subscription Renewals:
Jonathan Mooney – jonathan.mooney@informa.com
+44 (0) 20 7017 6797
Customer Services:
subscriptions@informa.com
+44 (0) 20 7017 5540
Marketing
Marketing Manager:
Ali Asaadi – ali.asaadi@informa.com
Publisher
Kelly Furneaux – kelly.furneaux@informa.com | Meet the team
Editorial team
Analysts
Editorial Board
Editorial Correspondents
Other Scrip Regulatory Affairs enables companies to:  | Make faster, better strategic decisions | | | Accelerate regulatory application processes | | | Achieve faster time to market for drugs & medical devices | | | Minimise regulatory compliance costs | | | Maximise market share in existing and new sectors | |
